NCT03862963

Brief Summary

The Republic of the Marshall Islands has the highest prevalence of type 2 diabetes (T2D) in the world. This clinical trial tested whether a community-based, intensive, plant-rich lifestyle intervention with exercise is more effective for treating and managing T2D in the Republic of the Marshall Islands than the standard of diabetes care. The intensive lifestyle intervention consisted of a plant-rich diet and moderate exercise. It centered around a 12-week program of counseling and instruction on healthy eating, exercise, and stress management, as well as hands-on cooking classes and prepared meals. Cardiometabolic outcomes were assessed throughout the intervention and at 24 weeks. The present study is the first randomized clinical trial ever conducted in the Republic of the Marshall Islands and the first lifestyle intervention trial conducted in Micronesia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Jun 2006

Typical duration for not_applicable type-2-diabetes-mellitus

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2008

Completed
10.6 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 5, 2019

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

2.2 years

First QC Date

March 3, 2019

Last Update Submit

May 15, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Fasting glucose

    mg/dl

    Change from Week 0 to Week 24

  • HbA1c

    Percent

    Change from Week 0 to Week 24

  • Fasting insulin

    mU/l

    Change from Week 0 to Week 24

  • HOMA-IR

    Insulin resistance as measured by HOMA-IR

    Change from Week 0 to Week 24

  • Usage of diabetes medications

    Number as measured by the medication effect score

    Change from Week 0 to Week 24

Secondary Outcomes (7)

  • Cholesterol (total, HDL, LDL) and triglycerides

    Change from Week 0 to Week 24

  • Blood pressure

    Change from Week 0 to Week 24

  • Heart rate

    Change from Week 0 to Week 24

  • High-sensitivity C-reactive protein

    Change from Week 0 to Week 24

  • Body weight

    Change from Week 0 to Week 24

  • +2 more secondary outcomes

Study Arms (2)

Standard of Diabetes Care

ACTIVE COMPARATOR

Standard of diabetes care in the Marshall Islands

Behavioral: Standard of diabetes care

Lifestyle Intervention

EXPERIMENTAL

Plant-based, whole foods diet with moderate exercise

Behavioral: Lifestyle Intervention

Interventions

The standard of diabetes care consisted of standard treatment protocols used by the MOH Diabetes Clinic. These included placing T2D patients on anti-hyperglycemic agents appropriate to their HbA1c levels (including sulfonylureas, metformin, and insulin) and providing oral and written information about the importance of maintaining a healthy weight, eating a healthy diet, and getting regular exercise. Participants in the control group were instructed not to make changes in their diet and activity levels during the study.

Standard of Diabetes Care

The lifestyle intervention consisted of a high-fiber, low-fat, mostly plant-based diet and 30-60 minutes per day of culturally-relevant, moderate intensity exercise. Participants initially received 12 weeks of group educational classes and some prepared meals and then followed the lifestyle intervention on their own for the remaining 12 weeks. Group classes included informative sessions on healthy eating, exercise (both aerobic and strength training), and stress management, as well as hands-on cooking classes. Classes were delivered as a combination of PowerPoint presentations, practical workshops, dine-outs, shopping tours, and cooking classes with spouses.

Lifestyle Intervention

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resident of the Republic of Marshall Islands
  • Aged 18 - 75 years
  • HbA1c ≥ 8.0% or diagnosed with T2D and taking diabetes medication
  • Medical clearance to participate from Diabetes Wellness Center (DWC) physicians.

You may not qualify if:

  • Recent (≤3 months) change in a diabetes-related medication dosage
  • A physical or medical condition that would impede participation in the lifestyle intervention (e.g., wheel-chair bound, unstable angina)
  • Evidence of significant coronary heart disease
  • Previous participation in an intensive lifestyle intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Hanick CJ, Peterson CM, Davis BC, Sabate J, Kelly JH Jr. A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial. Diabetologia. 2025 Feb;68(2):308-319. doi: 10.1007/s00125-024-06272-8. Epub 2024 Sep 21.

  • Davis BC, Jamshed H, Peterson CM, Sabate J, Harris RD, Koratkar R, Spence JW, Kelly JH Jr. An Intensive Lifestyle Intervention to Treat Type 2 Diabetes in the Republic of the Marshall Islands: Protocol for a Randomized Controlled Trial. Front Nutr. 2019 Jun 5;6:79. doi: 10.3389/fnut.2019.00079. eCollection 2019.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • John H Kelly, M.D.

    Loma Linda University; Black Hills Lifestyle Medicine Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel-arm study, although the control group was allowed to crossover after completing the control condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 3, 2019

First Posted

March 5, 2019

Study Start

June 1, 2006

Primary Completion

July 31, 2008

Study Completion

July 31, 2008

Last Updated

May 16, 2023

Record last verified: 2023-05